Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Chinook Therapeutics Inc

CUSIP: 16961L906 | 5 institutional holders

Quarters

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile